Plasma-free fatty acids, fatty acid-binding protein 4, and mortality in older adults (from the Cardiovascular Health Study).

[1]  D. Mozaffarian,et al.  Fatty acid‐binding protein 4 and incident heart failure: the Cardiovascular Health Study , 2013, European journal of heart failure.

[2]  H. Brenner,et al.  Circulating Adipocyte Fatty Acid-Binding Protein Levels and Cardiovascular Morbidity and Mortality in Patients With Coronary Heart Disease: A 10-year Prospective Study , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[3]  D. Siscovick,et al.  Plasma free fatty acids and risk of atrial fibrillation (from the Cardiovascular Health Study). , 2012, The American journal of cardiology.

[4]  D. Siscovick,et al.  Plasma Fatty Acid–Binding Protein 4, Nonesterified Fatty Acids, and Incident Diabetes in Older Adults , 2012, Diabetes Care.

[5]  D. Atar,et al.  Fatty Acid Binding Protein 4 Is Associated with Carotid Atherosclerosis and Outcome in Patients with Acute Ischemic Stroke , 2011, PloS one.

[6]  K. Shimamoto,et al.  Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease , 2011, PloS one.

[7]  E. Karlsson,et al.  The burden of obesity on infectious disease , 2010, Experimental biology and medicine.

[8]  AT Murugan,et al.  Obesity and respiratory diseases , 2008, Chronic respiratory disease.

[9]  G. Boden.  Obesity and free fatty acids. , 2008, Endocrinology and metabolism clinics of North America.

[10]  P. Sham,et al.  Circulating Adipocyte-Fatty Acid Binding Protein Levels Predict the Development of the Metabolic Syndrome: A 5-Year Prospective Study , 2007, Circulation.

[11]  C. Magnan,et al.  Free fatty acids and insulin resistance , 2007, Current opinion in clinical nutrition and metabolic care.

[12]  W. März,et al.  Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. , 2006, The Journal of clinical endocrinology and metabolism.

[13]  L. Makowski,et al.  Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses. , 2004, The Journal of nutrition.

[14]  J. Pankow,et al.  Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study. , 2004, Diabetes care.

[15]  A. Aljada,et al.  Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. , 2003, Diabetes.

[16]  G. Dagenais,et al.  Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study. , 2002, Atherosclerosis.

[17]  P. Ducimetiere,et al.  High plasma nonesterified fatty acids are predictive of cancer mortality but not of coronary heart disease mortality: results from the Paris Prospective Study. , 2001, American journal of epidemiology.

[18]  R. Bergman,et al.  Free Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus , 2000, Trends in Endocrinology & Metabolism.

[19]  L. Groop,et al.  High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[20]  P. J. Randle,et al.  Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. , 1998, Diabetes/metabolism reviews.

[21]  B. Balkau,et al.  High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study. , 1998, International journal of epidemiology.

[22]  D. Wilson,et al.  Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. , 1997, The American journal of pathology.

[23]  R. Bergman,et al.  Free Fatty Acid as a Link in the Regulation of Hepatic Glucose Output by Peripheral Insulin , 1995, Diabetes.

[24]  L H Kuller,et al.  Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.

[25]  T. Byers,et al.  Relation of body fat distribution to ischemic heart disease. The National Health and Nutrition Examination Survey I (NHANES I) Epidemiologic Follow-up Study. , 1995, American journal of epidemiology.

[26]  M. Cushman,et al.  Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.

[27]  P. Ducimetiere,et al.  Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris Prospective Study. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[28]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[29]  A S Leon,et al.  A questionnaire for the assessment of leisure time physical activities. , 1978, Journal of chronic diseases.

[30]  M. Nusynowitz,et al.  THYROTOXICOSIS DUE TO " SILENT " THYROIDITIS , 1975, The Lancet.

[31]  M. Oliver,et al.  A metabolic cause for arrhythmias during acute myocardial hypoxia. , 1970, Lancet.